Counterfeit Drugs Health, Social & Economic Impact

Counterfeit drugs pose a public health hazard, waste consumer income, and reduce the incentive to engage in research and development and innovation. Stronger state licensure supervision of drug suppliers would be helpful. Technological approaches, such as the Radio Frequency Identification devices, should also be considered. Finally, counterfeit drugs may raise concerns among consumers about the safety and reduce patient medication adherence.

Counterfeit drugs are not necessarily of the quality they purport to be and may be mislabeled with respect to identity and/or source. They can be imported, smuggled or manufactured locally by large consortia in large factories and establishments equipped with the most modem equipment, or by small-time operators in smaller, often poorly equipped facilities.

One in 10 drugs sold in developing countries is fake or substandard, leading to tens of thousands of deaths, many of them of African children given ineffective treatments for pneumonia and malaria, health officials said on Tuesday. In a major review of the problem, the World Health Organization (WHO) said that bogus drugs are growing threats as increased pharmaceutical trade, including Internet sales; open the door to sometimes toxic products.

Trade in counterfeit drugs appears to be widespread internationally and affects both developing and developed countries. The spread of counterfeit drugs is generally more pronounced in those countries where the manufacture, importation, distribution, supply, and sale of drugs are less regulated and enforcement may be weak. Current information indicates that drug counterfeiting is becoming more and more sophisticated, and thus the responsible authorities in the Member States are advised to keep this issue under constant review.

Webinar Jan 01 2026, Thursday 01:00 PM EDT 60 Minutes Intermediate Level Code: GRC0000272

  • Definition of counterfeit medicines
  • Impact on public health
  • Impact on economics
  • Factors facilitating counterfeiting
  • Measures to be taken for facing counterfeiting

  • Regulators
  • Quality assurance in the pharma industry
  • Pharmacist
  • Anyone interested in public health issues

  • To know the great risks of drug counterfeiting
  • To know the impact of drug counterfeiting on both public health
  • To impact of drug counterfeiting on macro & microeconomics
  • To know how to face this problem

MOHAMMAD ELNADI
MOHAMMAD ELNADI
20 Years

Mohammad is a highly accomplished pharmaceutical professional with over 20 years of experience in the pharmaceutical industry, specializing in business development, regulatory affairs, supply chain management, and international training. As a co-founder of the Arab Pharma Experts Association (APEA), Mohammad has established himself as a trusted expert in the field, combining his deep regulatory knowledge with strong business acumen to drive success in both local and international markets.
Mohammad began his career after earning a bachelor’s degree in Pharmaceutical Science from the University of Cairo in 2005. He quickly gained hands-on experience in research and development (R&D) and production of pharmaceutical dosage forms, as well as in coordinating contract manufacturing activities. His passion for continuous learning led him to pursue a postgraduate certificate in management from the American University in Cairo (AUC), where he honed his skills in marketing, project management, finance, and organizational behavior. Over the years, Mohammad has held several senior management roles, including Business Development Senior Officer, Supply Chain Manager, and Product development project manager at Elrazy Pharmaceuticals Co. In these positions, he successfully led market access projects, negotiated deals with overseas agents, and established supply chain strategies that aligned with the company’s overall goals. His efforts have enabled Elrazy Pharmaceuticals to expand its presence in key markets across Africa, ASEAN, and the GCC regions.In addition to his corporate roles, Mohammad has served as an independent pharmaceutical consultant and trainer, working with organizations such as IPI Academy in London and Pharmastate Academy in Delhi. He has delivered a wide range of training courses on topics such as Regulatory landscape, regulatory project management, supply chain optimization, and risk management. His expertise has benefited professionals from leading pharmaceutical companies across Egypt, UAE, KSA, Sudan, Spain, Portugal, Sweden & beyond.Mohammad’s extensive experience also includes roles as Managing Director of REYADA PRO for pharmaceutical services and consultancy, where he provided strategic guidance to clients, and as Regulatory Business Development Manager at REG EXPERTS, where he helped companies navigate complex regulatory landscapes. His ability to bridge the gap between regulatory compliance and business strategy has made him a sought-after expert in the industry. As an international trainer, Mohammad has conducted numerous online and offline courses, sharing his knowledge with professionals from diverse geographical regions. His training programs cover critical areas such as MENA region guidelines for drug registration, pharmaceutical supply chain management, and product development. His practical approach and real-world insights have earned him a reputation as a dynamic and engaging trainer. Mohammad’s educational background is complemented by a wide range of professional certifications, including Lean Green Belt, QMS Lead Auditor ISO 9001, and a Data Analytics Nanodegree from Udacity. He is also a certified business analyst and has completed advanced courses in strategic marketing, communication skills, and problem-solving. With a proven track record of driving cost efficiency, regulatory compliance, and market expansion, Mohammad continues to make significant contributions to the pharmaceutical industry. His unique blend of regulatory expertise, business development skills, and training capabilities positions him as a key player in shaping the future of pharmaceutical manufacturing and supply chain management.

  • 60 Mins | Nov 04, Tue , 01:00 PM EDT

The price of medicines is one of the factors that can limit the affordability of medicines to the population.  So...

MOHAMMAD ELNADI By MOHAMMAD ELNADI

  • 60 Mins | Jan 01, Thu , 01:00 PM EDT

Regulatory strategy in the pharmaceutical industry refers to the plan put in place by a pharmaceutical company to ensure...

MOHAMMAD ELNADI By MOHAMMAD ELNADI

  • 60 Mins | Jan 01, Thu , 01:00 PM EDT

The price of medicines is one of the factors that can limit the affordability of medicines to the population. So there...

MOHAMMAD ELNADI By MOHAMMAD ELNADI

  • Oct 27, Monday | 01:00 PM EDT | 75 Mins

Tattoos were always associated with sailors, marines, and bikers. Not today. Over the past few decades, there has been r...

  • Oct 27, Monday | 01:00 PM EDT | 60 Mins

This webinar is for you if you ever find yourself in a difficult emotional situation where a cool head is necessary. Th...

  • Oct 27, Monday | 08:12 PM EDT | 90 Mins

Nisi earum est dicta ab perspiciatis expedita sint. Sint voluptatem deserunt autem rerum quia possimus ea asperiores. Fa...

By